A recall of diabetes drugs has expanded to four lots of the widely used type 2 diabetes medication, metformin. They are being recalled due to possible contamination with a potentially cancer-causing compound. Indian pharmaceutical company Marksans Pharma Limited is recalling metformin hydrochloride extended-release tablets because their levels of NDMA, a 'probable human carcinogen,' were higher […]

The post Diabetes Drug Recalled Expanded Due to Cancer-Causing Contaminant appeared first on BlackDoctor.org.